Brief: Takara Bio Inc - To End Joint Development And Sales Contract Of Gene Therapy Drug Ny-Eso-1・Sitcr With Otsuka Pharmaceutical
10/11/2022 06:47
Nov 10 (Reuters) - Otsuka Holdings Co Ltd 4578.T :
* TO END JOINT DEVELOPMENT AND SALES CONTRACT OF GENE
THERAPY DRUG
NY-ESO-1・SITCRⓇ WITH OTSUKA PHARMACEUTICAL
Source text for Eikon: ID:nTSwj891f3
Further company coverage: 4578.T